Determinants of Quality of Life in Myasthenia Gravis Patients

Background: Although approximately half of myasthenia gravis (MG) patents achieve remission, for the remaining group MG is often a life-long disease. Better understanding of the determinants of Quality of Life (QoL) in MG is needed to optimize treatment goals in chronic cases. Materials and Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczudlik, Piotr, Sobieszczuk, Ewa, Szyluk, Beata, Lipowska, Marta, Kubiszewska, Justyna, Kostera-Pruszczyk, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538807/
https://www.ncbi.nlm.nih.gov/pubmed/33071942
http://dx.doi.org/10.3389/fneur.2020.553626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538807/
https://www.ncbi.nlm.nih.gov/pubmed/33071942
http://dx.doi.org/10.3389/fneur.2020.553626

Ejemplares similares